Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Krupp

Showing results (101-110 of 153) with videos related to

Pageof 16
Sort By:
Neuroimage|June 12, 2013
Metabolomic approach to human brain spectroscopy identifies associations between clinical features and the frontal lobe metabolome in multiple sclerosisLisa K Vingara, Hui Jing Yu, Mark E Wagshul, et al.
Journal of the International Neuropsychological Society : JINS|October 11, 2005
Perceived cognitive dysfunction and observed neuropsychological performance: longitudinal relation in persons with multiple sclerosisChristopher Christodoulou, Patricia Melville, William F Scherl, et al.
Psychological Reports|December 14, 2004
Normative data for the selective reminding test: a random digit dialing sampleWilliam F Scherl, Lauren B Krupp, Christopher Christodoulou, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 24, 2011
Visual-cognitive processing deficits in pediatric multiple sclerosisA M Smerbeck, J Parrish, D Serafin, et al.
Neuroimage|November 9, 2011
Multiple white matter tract abnormalities underlie cognitive impairment in RRMSHui Jing Yu, Christopher Christodoulou, Vikram Bhise, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 8, 2009
Fatigue and quality of life in pediatric multiple sclerosisWilliam S MacAllister, Christopher Christodoulou, Regina Troxell, et al.
Multiple Sclerosis and Related Disorders|February 15, 2022
A novel disease specific scale to characterize the symptoms and impacts of fatigue in US adults with relapsing multiple sclerosis: A real-world studyMarion Azoulai, Tiphaine Lévy-Heidmann, Valentin Morisseau, et al.
Annals of Neurology|October 27, 2010
A phase 3 trial of extended release oral dalfampridine in multiple sclerosisAndrew D Goodman, Theodore R Brown, Keith R Edwards, et al.
Neurology|November 1, 1995
Fatigue therapy in multiple sclerosis: results of a double-blind, randomized, parallel trial of amantadine, pemoline, and placeboL B Krupp, P K Coyle, C Doscher, et al.
Lancet (London, England)|March 3, 2009
Sustained-release oral fampridine in multiple sclerosis: a randomised, double-blind, controlled trialAndrew D Goodman, Theodore R Brown, Lauren B Krupp, et al.
Pageof 16

Showing results (101-110 of 153) with videos related to

Sort By:
Pageof 16
Neuroimage|June 12, 2013
Metabolomic approach to human brain spectroscopy identifies associations between clinical features and the frontal lobe metabolome in multiple sclerosisLisa K Vingara, Hui Jing Yu, Mark E Wagshul, et al.
Journal of the International Neuropsychological Society : JINS|October 11, 2005
Perceived cognitive dysfunction and observed neuropsychological performance: longitudinal relation in persons with multiple sclerosisChristopher Christodoulou, Patricia Melville, William F Scherl, et al.
Psychological Reports|December 14, 2004
Normative data for the selective reminding test: a random digit dialing sampleWilliam F Scherl, Lauren B Krupp, Christopher Christodoulou, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 24, 2011
Visual-cognitive processing deficits in pediatric multiple sclerosisA M Smerbeck, J Parrish, D Serafin, et al.
Neuroimage|November 9, 2011
Multiple white matter tract abnormalities underlie cognitive impairment in RRMSHui Jing Yu, Christopher Christodoulou, Vikram Bhise, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 8, 2009
Fatigue and quality of life in pediatric multiple sclerosisWilliam S MacAllister, Christopher Christodoulou, Regina Troxell, et al.
Multiple Sclerosis and Related Disorders|February 15, 2022
A novel disease specific scale to characterize the symptoms and impacts of fatigue in US adults with relapsing multiple sclerosis: A real-world studyMarion Azoulai, Tiphaine Lévy-Heidmann, Valentin Morisseau, et al.
Annals of Neurology|October 27, 2010
A phase 3 trial of extended release oral dalfampridine in multiple sclerosisAndrew D Goodman, Theodore R Brown, Keith R Edwards, et al.
Neurology|November 1, 1995
Fatigue therapy in multiple sclerosis: results of a double-blind, randomized, parallel trial of amantadine, pemoline, and placeboL B Krupp, P K Coyle, C Doscher, et al.
Lancet (London, England)|March 3, 2009
Sustained-release oral fampridine in multiple sclerosis: a randomised, double-blind, controlled trialAndrew D Goodman, Theodore R Brown, Lauren B Krupp, et al.
Pageof 16